IGC Subsidiary Partners with Confiprosper Fintech for Global Expansion

IGC Pharma Enters Strategic Partnership

India Globalization Capital, Inc. (IGC) has announced that its subsidiary, IGC Pharma, has entered into a cooperation agreement with Confiprosper Fintech Co., Ltd. This strategic partnership marks a significant step in IGC's global expansion plans, particularly in the pharmaceutical sector 1

1

Expanding Market Reach

The collaboration between IGC Pharma and Confiprosper Fintech is set to open new doors for both companies. Confiprosper Fintech, with its established presence in Southeast Asia and Latin America, will provide IGC Pharma with valuable access to these markets. This move aligns with IGC's strategy to broaden its international footprint and tap into emerging pharmaceutical markets 1

1

Focus on Alzheimer's Treatment

One of the key aspects of this partnership is the focus on IGC Pharma's flagship product, IGC-AD1. This investigational drug is currently undergoing Phase 2 clinical trials for the treatment of agitation in dementia due to Alzheimer's disease. The collaboration with Confiprosper Fintech is expected to accelerate the development and potential commercialization of IGC-AD1 in new markets 2

2

Leveraging Fintech Expertise

Confiprosper Fintech brings to the table its expertise in financial technology and market access. This partnership is expected to facilitate smoother financial transactions and potentially streamline the process of bringing IGC Pharma's products to new markets. The fintech company's established networks in Southeast Asia and Latin America could prove instrumental in navigating regulatory landscapes and establishing distribution channels 1

1

Related Stories

VCI Global Joins AI Computing Alliance to Establish Center in Malaysia

IGC Pharma Advances AI-Driven Alzheimer's Research and Treatment in Q1 2026

Genius Group Announces $33 Million Rights Offering to Boost Bitcoin Treasury

Genius Group Restructures Board with Four New Appointees for Global AI-Powered Education Expansion

Potential Impact on Alzheimer's Treatment

The collaboration between IGC Pharma and Confiprosper Fintech holds promise for advancing Alzheimer's treatment options globally. With the increasing prevalence of Alzheimer's disease worldwide, expanding access to potential treatments like IGC-AD1 could have significant implications for patients and healthcare systems in Southeast Asia and Latin America 2

2

Future Prospects

This strategic partnership represents a pivotal moment for IGC and its subsidiary, IGC Pharma. By joining forces with Confiprosper Fintech, the company is positioning itself for growth in key international markets. The success of this collaboration could pave the way for further expansion and potentially accelerate the development and distribution of innovative pharmaceutical solutions for neurodegenerative diseases 1

1

2